EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Reply to “Methodological Concerns in ‘Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma’”

Da-Long Yang, Jian-Li Huang, Hong-Gui Qin, Liang Ma, Jian-Hong Zhong, GUIDANCE Investigators

Liver Cancer · 11.06.2026 · 1-2

DOI: 10.1159/000553001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver Cancer, online erschienen am 11.06.2026. Verfasst von Da-Long Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Guangxi Medical University, Nanning, China. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Clinical complete responseHepatocellular carcinomaPD-1 inhibitor

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Guangxi Medical University, Nanning, China.

Zitieren

APA

Yang, D. L., Huang, J. L., Qin, H. G., Ma, L., Zhong, J. H., & GUIDANCE Investigators (2026). Reply to “Methodological Concerns in ‘Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma’”. Liver Cancer, 1-2. https://doi.org/10.1159/000553001

Vancouver

Yang DL, Huang JL, Qin HG, Ma L, Zhong JH, GUIDANCE Investigators. Reply to “Methodological Concerns in ‘Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma’”. Liver Cancer. 2026:1-2. doi:10.1159/000553001

BibTeX
@article{Yang2026,
  author = {Yang, Da-Long and Huang, Jian-Li and Qin, Hong-Gui and Ma, Liang and Zhong, Jian-Hong and GUIDANCE Investigators, GUIDANCE Investigators},
  title = {Reply to “Methodological Concerns in ‘Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma’”},
  journal = {Liver Cancer},
  year = {2026},
  pages = {1--2},
  doi = {10.1159/000553001}
}
Kostenlos starten →